NUCRYST Pharmaceuticals Corp. (USA) (NCST)
$1.75
0.01 (+0.57%)
| CAPS Rating |
|
|---|---|
| Open | $1.73 |
| Previous Close | $1.74 |
| Daily Range | $1.73 - $1.76 |
| 52-Week Range | $0.25 - $1.76 |
| Market Cap | $32.07M |
| P/E Ratio | 173.00 |
| Dividend (Yield) | 0.80 (46.00%) |
| Volume | 85,615 |
| Average Daily Volume | 75,000 |
NCST
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NCST Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
Related News and Articles
- 4-Star Stocks Poised to Pop: Cytori Therapeutics – The Motley Fool
- 52-Week Highs! What's Going On? – The Motley Fool
- Don't Ignore These Incredible Returns – The Motley Fool
- 5-Star Stocks Poised to Pop: Stryker – The Motley Fool
- This Company Is a Value Stock! Isn't It? – The Motley Fool
- 4-Star Stocks Poised to Pop: Intuitive Surgical – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Psst … Here's How Your Company Will Do – The Motley Fool
- A Big Upgrade for Electro-Optical Sciences – The Motley Fool
- Wednesday's Biggest Stock Stars – The Motley Fool
- Slicing and Dicing Intuitive Surgical's Quarter – The Motley Fool
- 3 Stocks Springing Back – The Motley Fool
- The Heart Company's Disheartening Forecast – The Motley Fool
- The HPV Vaccine Wars of 2010 – The Motley Fool
- 5 Superball Stocks – The Motley Fool
- Winning Formula: A Unique Combination – The Motley Fool
- Boston Scientific Pays Up – The Motley Fool
- Habits You Won't Want to Kick – The Motley Fool
- Health-Care Reform: Pocketbook or Portfolio? – The Motley Fool
- Insider Information You Can't Afford to Ignore – The Motley Fool
RSS Headlines
Fool UK
